PEDS Advance Access published online on July 31, 2006
Protein Engineering Design and Selection, doi:10.1093/protein/gzl030
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Crump Institute for Molecular Imaging, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA
* To whom correspondence should be addressed. An anti-carcinoembryonic antigen (CEA) antibody fragment, the anti-CEA diabody, was fused to the bioluminescence enzyme Renilla luciferase (RLuc) to generate a novel optical imaging probe. Native RLuc or one of two stabilized variants (RLucC124A, RLuc8) was used as the bioluminescent moiety. A bioluminescence ELISA showed that diabody-luciferase could simultaneously bind to CEA and emit light. In vivo optical imaging of tumor-bearing mice demonstrated specific targeting of diabody-RLuc8 to CEA-positive xenografts, with a tumor:background ratio of 6.0 ± 0.8 at 6 h after intravenous injection, compared with antigen-negative tumors at 1.0 ± 0.1 (P = 0.05). Targeting and distribution was also evaluated by microPET imaging using 124I-diabody-RLuc8 and confirmed that the optical signal was due to antibody-mediated localization of luciferase. Renilla luciferase, fused to biospecific sequences such as engineered antibodies, can be administered systemically to provide a novel, sensitive method for optical imaging based on expression of cell surface receptors in living organisms.
Received January 11, 2006
Revised May 3, 2006
Accepted June 14, 2006
Article
Bifunctional antibody-Renilla luciferase fusion protein for in vivo optical detection of tumors
Katy M. Venisnik 1, Tove Olafsen 1, Andreas M. Loening 2, Meera Iyer 3, Sanjiv S. Gambhir 2, and Anna M. Wu 1 *
2 Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University, 300 Pasteur Drive, Stanford CA 94305, USA; Department of Bioengineering, Stanford University, 300 Pasteur Drive, Stanford CA 94305, USA
3 Crump Institute for Molecular Imaging, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA; Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University, 300 Pasteur Drive, Stanford CA 94305, USA
Anna M. Wu, E-mail: awu{at}mednet.ucla.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Wu, K. Mino, H. Akimoto, M. Kawabata, K. Nakamura, M. Ozaki, and Y. Ohmiya In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dye PNAS, September 15, 2009; 106(37): 15599 - 15603. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Brown, C. G. Irvin, G. B. Allen III, S. D. Shapiro, W. J. Martin, M. R. J. Kolb, D. M. Hyde, G. F. Nieman, D. D. Cody, M. Ishii, et al. An Official ATS Conference Proceedings: Advances in Small-Animal Imaging Application to Lung Pathophysiology Proceedings of the ATS, July 15, 2008; 5(5): 591 - 600. [Full Text] [PDF] |
||||
![]() |
E. J. Akins and P. Dubey Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer J. Nucl. Med., June 1, 2008; 49(Suppl_2): 180S - 195S. [Abstract] [Full Text] [PDF] |
||||


